Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy

Zhao Yang, Neil E. Bowles, Steven E. Scherer, Michael D. Taylor, Debra L. Kearney, Shuping Ge, Vyacheslav V. Nadvoretskiy, Gilberto DeFreitas, Blasé Carabello, Lois I. Brandon, Lisa M. Godsel, Kathleen J. Green, Jeffrey E. Saffitz, Hua Li, Gian Antonio Danieli, Hugh Calkins, Frank Marcus, Jeffrey Towbin

Research output: Contribution to journalArticle

203 Citations (Scopus)

Abstract

Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is characterized by progressive degeneration of the right ventricular myocardium, ventricular arrhythmias, fibrous-fatty replacement, and increased risk of sudden death. Mutations in 6 genes, including 4 encoding desmosomal proteins (Junctional plakoglobin (JUP), Desmoplakin (DSP), Plakophilin 2, and Desmoglein 2), have been identified in patients with ARVD/C. Mutation analysis of 66 probands identified 4 variants in DSP; V30M, Q90R, W233X, and R2834H. To establish a cause and effect relationship between those DSP missense mutations and ARVD/C, we performed in vitro and in vivo analyses of the mutated proteins. Unlike wild-type (WT) DSP, the N-terminal mutants (V30M and Q90R) failed to localize to the cell membrane in desomosome-forming cell line and failed to bind to and coimmunoprecipitate JUP. Multiple attempts to generate N-terminal DSP (V30M and Q90R) cardiac-specific transgenes have failed: analysis of embryos revealed evidence of profound ventricular dilation, which likely resulted in embryonic lethality. We were able to develop transgenic (Tg) mice with cardiac-restricted overexpression of the C-terminal mutant (R2834H) or WT DSP. Whereas mice overexpressing WT DSP had no detectable histologic, morphological, or functional cardiac changes, the R2834H-Tg mice had increased cardiomyocyte apoptosis, cardiac fibrosis, and lipid accumulation, along with ventricular enlargement and cardiac dysfunction in both ventricles. These mice also displayed interruption of DSP-desmin interaction at intercalated discs (IDs) and marked ultra-structural changes of IDs. These data suggest DSP expression in cardiomyocytes is crucial for maintaining cardiac tissue integrity, and DSP abnormalities result in ARVD/C by cardiomyocyte death, changes in lipid metabolism, and defects in cardiac development.

Original languageEnglish (US)
Pages (from-to)646-655
Number of pages10
JournalCirculation Research
Volume99
Issue number6
DOIs
StatePublished - Sep 1 2006
Externally publishedYes

Fingerprint

Desmoplakins
Arrhythmogenic Right Ventricular Dysplasia
Mutation
gamma Catenin
Cardiac Myocytes
Transgenic Mice
Desmoglein 2
Plakophilins
Desmin
Missense Mutation
Sudden Death
Transgenes
Lipid Metabolism
Cardiac Arrhythmias
Dilatation
Myocardium
Proteins
Fibrosis
Embryonic Structures

All Science Journal Classification (ASJC) codes

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. / Yang, Zhao; Bowles, Neil E.; Scherer, Steven E.; Taylor, Michael D.; Kearney, Debra L.; Ge, Shuping; Nadvoretskiy, Vyacheslav V.; DeFreitas, Gilberto; Carabello, Blasé; Brandon, Lois I.; Godsel, Lisa M.; Green, Kathleen J.; Saffitz, Jeffrey E.; Li, Hua; Danieli, Gian Antonio; Calkins, Hugh; Marcus, Frank; Towbin, Jeffrey.

In: Circulation Research, Vol. 99, No. 6, 01.09.2006, p. 646-655.

Research output: Contribution to journalArticle

Yang, Z, Bowles, NE, Scherer, SE, Taylor, MD, Kearney, DL, Ge, S, Nadvoretskiy, VV, DeFreitas, G, Carabello, B, Brandon, LI, Godsel, LM, Green, KJ, Saffitz, JE, Li, H, Danieli, GA, Calkins, H, Marcus, F & Towbin, J 2006, 'Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy', Circulation Research, vol. 99, no. 6, pp. 646-655. https://doi.org/10.1161/01.RES.0000241482.19382.c6
Yang, Zhao ; Bowles, Neil E. ; Scherer, Steven E. ; Taylor, Michael D. ; Kearney, Debra L. ; Ge, Shuping ; Nadvoretskiy, Vyacheslav V. ; DeFreitas, Gilberto ; Carabello, Blasé ; Brandon, Lois I. ; Godsel, Lisa M. ; Green, Kathleen J. ; Saffitz, Jeffrey E. ; Li, Hua ; Danieli, Gian Antonio ; Calkins, Hugh ; Marcus, Frank ; Towbin, Jeffrey. / Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. In: Circulation Research. 2006 ; Vol. 99, No. 6. pp. 646-655.
@article{ec5cddcbf52a466c91c32f4ba0c576c0,
title = "Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy",
abstract = "Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is characterized by progressive degeneration of the right ventricular myocardium, ventricular arrhythmias, fibrous-fatty replacement, and increased risk of sudden death. Mutations in 6 genes, including 4 encoding desmosomal proteins (Junctional plakoglobin (JUP), Desmoplakin (DSP), Plakophilin 2, and Desmoglein 2), have been identified in patients with ARVD/C. Mutation analysis of 66 probands identified 4 variants in DSP; V30M, Q90R, W233X, and R2834H. To establish a cause and effect relationship between those DSP missense mutations and ARVD/C, we performed in vitro and in vivo analyses of the mutated proteins. Unlike wild-type (WT) DSP, the N-terminal mutants (V30M and Q90R) failed to localize to the cell membrane in desomosome-forming cell line and failed to bind to and coimmunoprecipitate JUP. Multiple attempts to generate N-terminal DSP (V30M and Q90R) cardiac-specific transgenes have failed: analysis of embryos revealed evidence of profound ventricular dilation, which likely resulted in embryonic lethality. We were able to develop transgenic (Tg) mice with cardiac-restricted overexpression of the C-terminal mutant (R2834H) or WT DSP. Whereas mice overexpressing WT DSP had no detectable histologic, morphological, or functional cardiac changes, the R2834H-Tg mice had increased cardiomyocyte apoptosis, cardiac fibrosis, and lipid accumulation, along with ventricular enlargement and cardiac dysfunction in both ventricles. These mice also displayed interruption of DSP-desmin interaction at intercalated discs (IDs) and marked ultra-structural changes of IDs. These data suggest DSP expression in cardiomyocytes is crucial for maintaining cardiac tissue integrity, and DSP abnormalities result in ARVD/C by cardiomyocyte death, changes in lipid metabolism, and defects in cardiac development.",
author = "Zhao Yang and Bowles, {Neil E.} and Scherer, {Steven E.} and Taylor, {Michael D.} and Kearney, {Debra L.} and Shuping Ge and Nadvoretskiy, {Vyacheslav V.} and Gilberto DeFreitas and Blas{\'e} Carabello and Brandon, {Lois I.} and Godsel, {Lisa M.} and Green, {Kathleen J.} and Saffitz, {Jeffrey E.} and Hua Li and Danieli, {Gian Antonio} and Hugh Calkins and Frank Marcus and Jeffrey Towbin",
year = "2006",
month = "9",
day = "1",
doi = "10.1161/01.RES.0000241482.19382.c6",
language = "English (US)",
volume = "99",
pages = "646--655",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy

AU - Yang, Zhao

AU - Bowles, Neil E.

AU - Scherer, Steven E.

AU - Taylor, Michael D.

AU - Kearney, Debra L.

AU - Ge, Shuping

AU - Nadvoretskiy, Vyacheslav V.

AU - DeFreitas, Gilberto

AU - Carabello, Blasé

AU - Brandon, Lois I.

AU - Godsel, Lisa M.

AU - Green, Kathleen J.

AU - Saffitz, Jeffrey E.

AU - Li, Hua

AU - Danieli, Gian Antonio

AU - Calkins, Hugh

AU - Marcus, Frank

AU - Towbin, Jeffrey

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is characterized by progressive degeneration of the right ventricular myocardium, ventricular arrhythmias, fibrous-fatty replacement, and increased risk of sudden death. Mutations in 6 genes, including 4 encoding desmosomal proteins (Junctional plakoglobin (JUP), Desmoplakin (DSP), Plakophilin 2, and Desmoglein 2), have been identified in patients with ARVD/C. Mutation analysis of 66 probands identified 4 variants in DSP; V30M, Q90R, W233X, and R2834H. To establish a cause and effect relationship between those DSP missense mutations and ARVD/C, we performed in vitro and in vivo analyses of the mutated proteins. Unlike wild-type (WT) DSP, the N-terminal mutants (V30M and Q90R) failed to localize to the cell membrane in desomosome-forming cell line and failed to bind to and coimmunoprecipitate JUP. Multiple attempts to generate N-terminal DSP (V30M and Q90R) cardiac-specific transgenes have failed: analysis of embryos revealed evidence of profound ventricular dilation, which likely resulted in embryonic lethality. We were able to develop transgenic (Tg) mice with cardiac-restricted overexpression of the C-terminal mutant (R2834H) or WT DSP. Whereas mice overexpressing WT DSP had no detectable histologic, morphological, or functional cardiac changes, the R2834H-Tg mice had increased cardiomyocyte apoptosis, cardiac fibrosis, and lipid accumulation, along with ventricular enlargement and cardiac dysfunction in both ventricles. These mice also displayed interruption of DSP-desmin interaction at intercalated discs (IDs) and marked ultra-structural changes of IDs. These data suggest DSP expression in cardiomyocytes is crucial for maintaining cardiac tissue integrity, and DSP abnormalities result in ARVD/C by cardiomyocyte death, changes in lipid metabolism, and defects in cardiac development.

AB - Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is characterized by progressive degeneration of the right ventricular myocardium, ventricular arrhythmias, fibrous-fatty replacement, and increased risk of sudden death. Mutations in 6 genes, including 4 encoding desmosomal proteins (Junctional plakoglobin (JUP), Desmoplakin (DSP), Plakophilin 2, and Desmoglein 2), have been identified in patients with ARVD/C. Mutation analysis of 66 probands identified 4 variants in DSP; V30M, Q90R, W233X, and R2834H. To establish a cause and effect relationship between those DSP missense mutations and ARVD/C, we performed in vitro and in vivo analyses of the mutated proteins. Unlike wild-type (WT) DSP, the N-terminal mutants (V30M and Q90R) failed to localize to the cell membrane in desomosome-forming cell line and failed to bind to and coimmunoprecipitate JUP. Multiple attempts to generate N-terminal DSP (V30M and Q90R) cardiac-specific transgenes have failed: analysis of embryos revealed evidence of profound ventricular dilation, which likely resulted in embryonic lethality. We were able to develop transgenic (Tg) mice with cardiac-restricted overexpression of the C-terminal mutant (R2834H) or WT DSP. Whereas mice overexpressing WT DSP had no detectable histologic, morphological, or functional cardiac changes, the R2834H-Tg mice had increased cardiomyocyte apoptosis, cardiac fibrosis, and lipid accumulation, along with ventricular enlargement and cardiac dysfunction in both ventricles. These mice also displayed interruption of DSP-desmin interaction at intercalated discs (IDs) and marked ultra-structural changes of IDs. These data suggest DSP expression in cardiomyocytes is crucial for maintaining cardiac tissue integrity, and DSP abnormalities result in ARVD/C by cardiomyocyte death, changes in lipid metabolism, and defects in cardiac development.

UR - http://www.scopus.com/inward/record.url?scp=33748741625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748741625&partnerID=8YFLogxK

U2 - 10.1161/01.RES.0000241482.19382.c6

DO - 10.1161/01.RES.0000241482.19382.c6

M3 - Article

VL - 99

SP - 646

EP - 655

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 6

ER -